2016
DOI: 10.21276/aimdr.2016.2.6.de1
|View full text |Cite
|
Sign up to set email alerts
|

Therapeutic Management of Recurrent Aphthous Stomatitis: A Review of the Growing Knowledge

Abstract: Recurrent aphthous stomatitis (RAS) is one of the common clinical oral diseases that produces painful ulcerations in the oral cavity .It is also called canker sore or mouth ulcer. Although , the clinical features and characteristics of this disease are easily defined , the etiology and the pathophysiology remain unclear. So as a result, the available treatments still remaining unsatisfactory with the ability to reduce the severity , healing time and the frequency of recurrence of ulceration with no permanent a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 40 publications
0
2
0
Order By: Relevance
“…There has been armamentarium of systemic drugs available like prednisolone, azathioprine, thalidomide, cyclosporine, methotrexate, dapsone, pentoxifylline and colchicine. 6 Apremilast is the new addition to this spectrum. Till date, there are no studies which conducted a head on comparison between apremilast and other conventional drugs like colchicine and dapsone.…”
Section: Discussionmentioning
confidence: 99%
“…There has been armamentarium of systemic drugs available like prednisolone, azathioprine, thalidomide, cyclosporine, methotrexate, dapsone, pentoxifylline and colchicine. 6 Apremilast is the new addition to this spectrum. Till date, there are no studies which conducted a head on comparison between apremilast and other conventional drugs like colchicine and dapsone.…”
Section: Discussionmentioning
confidence: 99%
“…In many patients, resolution of the systemic disorder gives rise to a reduced incidence and severity of the mucosal ulcerations. 2,3 The mucosal destruction in RAS patients appears to represent a T cellmediated immunologic reaction with production of tumor necrosis factor-alpha. However, the initiating causes are variable.…”
mentioning
confidence: 99%